| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37b416a8c0d2b0f1c3d6026d932027af |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-734
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42 |
| filingDate |
2017-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cd26fa46808025020ed69538ecde28a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c34bbf0c6d33b5e6c54cedc8a046c09a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dfaf56ba41dc2cf2de3fafdde6806dc6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f459df3c7e7279c5ed5f58aaa002cff4 |
| publicationDate |
2018-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2018052375-A1 |
| titleOfInvention |
Anti-dengue virus antibodies, polypeptides containing variant fc regions, and methods of use |
| abstract |
The disclosure provides anti-DENV antibodies and methods of making and using the same. Nucleic acids encoding anti- DENV antibodies and host cells comprising the nucleic acids are also provided. The anti-DENV antibodies have uses that include treating DENV infection. The disclosure also provided polypeptides containing a variant Fc region and methods of making the same. Nucleic acids encoding polypeptides and host cells comprising the nucleic acids are also provided. The polypeptides have uses that include treating a viral infection. Also claimed is a polypeptide comprising a Fc variant comprising at least one amino acid alteration in a parent Fc region, wherein the variant Fc region has a substantially decreased FcYR-binding activity and does not have a substantially decreased C1 q-binding activity when compared to the parent Fc region. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11590221-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022034920-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11332533-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11053308-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11464815-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019177543-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11780912-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11180548-B2 |
| priorityDate |
2016-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |